Valuation CASI Pharmaceuticals, Inc.

Stocks

Real-time OTC Markets 10:57:58 2026-06-03 EDT			5-day change	1st Jan Change
0.1052 ^USD	-2.09%		-18.25%	-87.61%

08-14	CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
06-02	CASI Pharmaceuticals, Inc. Announces Resignation of Barbara Krebs-Pohl as Director, Effective May 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	365.6	111.8	24.35	95.38	43.84	17.47
Change	-	-69.41%	-78.22%	291.63%	-54.03%	-60.16%
Enterprise Value (EV) ¹	302.5	65.43	-25.64	85.85	49.89	39.32
Change	-	-78.37%	-139.18%	434.86%	-41.88%	-21.19%
P/E	-6.75x	-2.96x	-0.59x	-3.55x	-1.11x	-0.33x
PBR	4.48x	1.32x	0.54x	3.96x	23.7x	-0.47x
PEG	-	0.1x	-0.1x	0.1x	-0x	-0.26x
Capitalization / Revenue	24.1x	3.71x	0.56x	2.82x	1.54x	0.84x
EV / Revenue	20x	2.17x	-0.59x	2.53x	1.75x	1.9x
EV / EBITDA	-9.65x	-1.96x	1.07x	-3.99x	-1.35x	-0.95x
EV / EBIT	-9.08x	-1.85x	0.97x	-3.4x	-1.27x	-0.92x
EV / FCF	-11.7x	-2.39x	1.47x	-6.26x	-3.28x	-60.4x
FCF Yield	-8.55%	-41.8%	67.9%	-16%	-30.5%	-1.66%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-4.372	-2.7	-3.01	-2.018	-2.56	-2.592
Distribution rate	-	-	-	-	-	-
Net sales ¹	15.14	30.17	43.11	33.88	28.54	20.71
EBITDA ¹	-31.35	-33.47	-24.07	-21.54	-36.88	-41.59
EBIT ¹	-33.31	-35.28	-26.49	-25.28	-39.21	-42.85
Net income ¹	-48.29	-36.65	-41.01	-26.94	-39.26	-48.06
Net Debt ¹	-63.18	-46.41	-49.99	-9.53	6.05	21.85
Reference price ²	29.5000	8.0000	1.7900	7.1600	2.8300	0.8500
Nbr of stocks (in thousands)	12,394	13,980	13,606	13,322	15,493	20,548
Announcement Date	3/30/21	3/28/22	4/26/23	3/28/24	3/31/25	5/15/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CASI PHARMACEUTICALS, INC.	-	-	-	-	2.87M
ELI LILLY AND COMPANY	35.07x	12.64x	25.79x	0.56%	1,093B
JOHNSON & JOHNSON	30.16x	-	-	1.98%	653B
ABBVIE INC.	33.05x	7.66x	15.93x	2.65%	458B
ROCHE HOLDING AG	20.11x	4.77x	11.83x	2.77%	355B
NOVARTIS AG	21.93x	5.66x	14.07x	2.83%	294B
ASTRAZENECA PLC	20.48x	4.23x	12x	2.08%	248B
AMGEN INC.	26.9x	6.98x	12.39x	2.37%	230B
NOVO NORDISK A/S	13.48x	4.8x	10.06x	3.81%	203B
GILEAD SCIENCES, INC.	-43.83x	6.34x	24.76x	2.3%	178B
Average	17.48x	6.63x	15.85x	2.37%	371.05B
Weighted average by Cap.	25.04x	8.32x	18.34x	1.93%